Hybiak J, Broniarek I, Kiryczyński G, Los LD, Rosik J, Machaj F et al (2020) Aspirin and its pleiotropic application. Eur J Pharmacol 866:172762
Article CAS PubMed Google Scholar
Woulfe D, Yang J, Brass L (2001) ADP and platelets: the end of the beginning. J Clin Invest 107(12):1503–5
Article CAS PubMed PubMed Central Google Scholar
Hankey GJ, Eikelboom JW (2006) Aspirin resistance. Lancet 367(9510):606–17
Article CAS PubMed Google Scholar
Ichikawa Y (1992) A new RV-PA conduit with a natural valve made of bovine jugular vein. Asaio J 38(3):M266-70
Article MathSciNet CAS PubMed Google Scholar
Rüffer A, Wittmann J, Potapov S, Purbojo A, Glöckler M, Koch AM et al (2012) Mid-term experience with the Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction. Eur J Cardiothorac Surg 42(6):988–95
Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Darragh RK (2006) Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft. Ann Thorac Surg 82(3):909–16
Armstrong AK, Balzer DT, Cabalka AK, Gray RG, Javois AJ, Moore JW et al (2014) One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv 7(11):1254–62
Kenny D, Rhodes JF, Fleming GA, Kar S, Zahn EM, Vincent J et al (2018) 3-Year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv 11(19):1920–9
Promphan W, Prachasilchai P, Siripornpitak S, Qureshi SA, Layangool T (2016) Percutaneous pulmonary valve implantation with the venus P-valve: clinical experience and early results. Cardiol Young 26(4):698–710
Kim RW (2018) Melody mitral valve replacement is no longer an experimental procedure. Circ Cardiovasc Interv 11(11):e007455
Article MathSciNet PubMed Google Scholar
Godart F, Baruteau AE, Petit J, Riou JY, Sassolas F, Lusson JR et al (2014) Transcatheter tricuspid valve implantation: a multicentre French study. Arch Cardiovasc Dis 107(11):583–91
McElhinney DB, Zhang Y, Levi DS, Georgiev S, Biernacka EK, Goldstein BH et al (2022) Reintervention and survival after transcatheter pulmonary valve replacement. J Am Coll Cardiol 79(1):18–32
McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM et al (2021) Multicenter study of endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 78(6):575–89
Sharma A, Cote AT, Hosking MCK, Harris KC (2017) A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types. JACC Cardiovasc Interv 10(14):1449–58
Shibbani K, Garg R, Zahn EM, McLennan D (2021) Aspirin use and transcatheter pulmonary valve replacement, the need for consistency. Pediatr Cardiol 42(7):1640–6
Goldstein BH, Bergersen L, Armstrong AK, Boe BA, El-Said H, Porras D et al (2020) Adverse events, radiation exposure, and reinterventions following transcatheter pulmonary valve replacement. J Am Coll Cardiol 75(4):363–76
Jewgenow P, Schneider H, Bökenkamp R, Hörer J, Cleuziou J, Foth R et al (2019) Subclinical thrombus formation in bioprosthetic pulmonary valve conduits. Int J Cardiol 281:113–8
Malekzadeh-Milani S, Ladouceur M, Patel M, Boughenou FM, Iserin L, Bonnet D et al (2015) Incidence and predictors of Melody® valve endocarditis: a prospective study. Arch Cardiovasc Dis 108(2):97–106
Jørgen B, Nikolai N, Lasse Holtan P, Ingunn T, Kathrin B (2021) Adjusting the dose in paediatric care: dispersing four different aspirin tablets and taking a proportion. Eur J Hosp Pharm 28(2):76
Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P (2006) Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost. 95(4):652–8
Article CAS PubMed Google Scholar
Haemonetics (2016) TEG® PlateletMapping® Assay’, Brochure, p 2. https://www.haemonetics.com/~/media/sharepoint/devices/teg/marketing/brochures/teg_plateletmapping/col-pp-000196-us_teg_plateletmapping_assay.pdf
Karon BS, Tolan NV, Koch CD, Wockenfus AM, Miller RS, Lingineni RK et al (2014) Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Clin Chem 60(12):1524–31
Article CAS PubMed Google Scholar
Haemonetics (2016) FDA Data K041502. https://www.accessdata.fda.gov/cdrh_docs/reviews/k140893.pdf
Ranucci M, Baryshnikova E (2020) Sensitivity of viscoelastic tests to platelet function. J Clin Med 9(1):189
Article CAS PubMed PubMed Central Google Scholar
Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG (2007) A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28(14):1702–8
Cattaneo M (2007) Laboratory detection of ‘aspirin resistance’: what test should we use (if any)? The opinions expressed in this article are necessarily not those of the Editors of European Heart Journal or of the European Society of Cardiology. Eur Heart J 28(14):1673–5
Michelson AD, Bhatt DL (2017) How I use laboratory monitoring of antiplatelet therapy. Blood 130(6):713–21
Article CAS PubMed Google Scholar
Blais N, Pharand C, Lordkipanidzé M, Sia YK, Merhi Y, Diodati JG (2009) Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost 102(2):404–11
Emani S, Zurakowski D, Mulone M, DiNardo JA, Trenor CC, Emani SM (2017) Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg 154(5):1723–30
Article CAS PubMed Google Scholar
Koh W, Rodts M, Nebbia A, Sawyer J, Henry B, Cooper DS (2022) Aspirin resistance in infants with shunt-dependent congenital heart disease. Cardiol Young 32(5):705–10
Emani S, Trainor B, Zurakowski D, Baird CW, Fynn-Thompson FE, Pigula FA et al (2014) Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg 148(3):810–4 (discussion 4–6)
Article CAS PubMed Google Scholar
Patregnani J, Klugman D, Zurakowski D, Sinha P, Freishtat R, Berger J et al (2016) High on aspirin platelet reactivity in pediatric patients undergoing the Fontan procedure. Circulation 134(17):1303–5
Article PubMed PubMed Central Google Scholar
Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T (2005) Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg 27(4):606–10
Regan IE, Cox D, Kelleher ST, Nolan B, Shaw K, Smith OP et al (2023) Towards a greater understanding of reduced response to aspirin in children with congenital heart disease post-cardiac surgery using immature platelet fraction. Thromb Res 233:101–8
Kern FH, Morana NJ, Sears JJ, Hickey PR (1992) Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 54(3):541–6
Article CAS PubMed Google Scholar
Cholette JM, Rubenstein JS, Alfieris GM, McDermott MP, Harmon WG, Vermilion R et al (2007) Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 84(4):1320–5
Mir A, Frank S, Journeycake J, Wolovitis J, Guleserian K, Heistein L et al (2015) Aspirin resistance in single-ventricle physiology: aspirin prophylaxis is not adequate to inhibit platelets in the immediate postoperative period. Ann Thorac Surg. 99(6):2158–64
Shantsila E, Lip GYH (2008) ‘Aspirin resistance’ or treatment non-compliance: which is to blame for cardiovascular complications? J Transl Med 6(1):47
Article PubMed PubMed Central Google Scholar
Kardas P, Dabrowa M, Witkowski K (2021) Adherence to treatment in paediatric patients—results of the nationwide survey in Poland. BMC Pediatr 21(1):16
Comments (0)